Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Retained Earnings Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Retained Earnings
-$528.5m
CAGR 3-Years
-30%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Retained Earnings
ÂŁ9.6B
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
17%
AstraZeneca PLC
LSE:AZN
Retained Earnings
$3.9B
CAGR 3-Years
-19%
CAGR 5-Years
-6%
CAGR 10-Years
-14%
Indivior PLC
LSE:INDV
Retained Earnings
-$162m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-11%
Hikma Pharmaceuticals PLC
LSE:HIK
Retained Earnings
$2.3B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
11%
Dechra Pharmaceuticals PLC
LSE:DPH
Retained Earnings
ÂŁ171m
CAGR 3-Years
-7%
CAGR 5-Years
6%
CAGR 10-Years
15%

See Also

What is Verona Pharma PLC's Retained Earnings?
Retained Earnings
-528.5m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Retained Earnings amounts to -528.5m USD.

What is Verona Pharma PLC's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-39%

Over the last year, the Retained Earnings growth was -41%. The average annual Retained Earnings growth rates for Verona Pharma PLC have been -30% over the past three years , -39% over the past five years .

Back to Top